Evogene Net Asset Quality Index
Evogene net asset quality index. Evogene (EVGN) has a Net Asset Quality Index of 66.1% as of September 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of ILA26.09 Million minus total liabilities of ILA8.83 Million yields net assets of ILA17.25 Million. A higher index indicates a stronger, lower-leverage balance sheet. See EVGN book value for net asset value and shareholders' equity analysis.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of Evogene (2006–2024)
Net asset quality index of Evogene from 2006 to 2024. This chart shows how Evogene's Net Asset Quality Index has evolved across 19 annual periods from 2006 to 2024. As of September 2025, the index stands at 66.1%, representing net assets of ILA17.25 Million against total assets of ILA26.09 Million ILA. Check EVGN capital-intensive asset ratio to assess the company's strategic physical and investment asset allocation.
Evogene Net Asset Quality Index by Year (2006–2024)
Evogene net asset quality index by year from 2006 to 2024. The table below presents the year-by-year Net Asset Quality Index for Evogene from 2006 to 2024, covering 19 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see Evogene stock valuation.
| Year | Quality Index | Net Assets (ILA) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 37.2% | ILA14.84 Million | ILA39.86 Million | ILA25.03 Million | ▼ -18.9 pp |
| 2023 | 56.1% | ILA28.68 Million | ILA51.10 Million | ILA22.42 Million | ▼ -5.9 pp |
| 2022 | 62.0% | ILA34.79 Million | ILA56.13 Million | ILA21.34 Million | ▼ -21.1 pp |
| 2021 | 83.1% | ILA63.42 Million | ILA76.30 Million | ILA12.88 Million | ▲ +4.0 pp |
| 2020 | 79.1% | ILA56.88 Million | ILA71.92 Million | ILA15.03 Million | ▼ -5.3 pp |
| 2019 | 84.4% | ILA60.22 Million | ILA71.36 Million | ILA11.15 Million | ▼ -1.3 pp |
| 2018 | 85.7% | ILA50.31 Million | ILA58.69 Million | ILA8.39 Million | ▼ -3.7 pp |
| 2017 | 89.4% | ILA69.38 Million | ILA77.60 Million | ILA8.22 Million | ▼ -1.5 pp |
| 2016 | 90.9% | ILA87.29 Million | ILA95.99 Million | ILA8.70 Million | ▼ -1.2 pp |
| 2015 | 92.1% | ILA103.75 Million | ILA112.59 Million | ILA8.84 Million | ▲ +1.2 pp |
| 2014 | 91.0% | ILA116.08 Million | ILA127.59 Million | ILA11.50 Million | ▲ +0.1 pp |
| 2013 | 90.8% | ILA124.75 Million | ILA137.31 Million | ILA12.56 Million | ▲ +16.4 pp |
| 2012 | 74.4% | ILA48.26 Million | ILA64.86 Million | ILA16.60 Million | ▲ +3.6 pp |
| 2011 | 70.8% | ILA48.09 Million | ILA67.89 Million | ILA19.80 Million | ▲ +31.8 pp |
| 2010 | 39.0% | ILA16.73 Million | ILA42.87 Million | ILA26.14 Million | ▼ -6.1 pp |
| 2009 | 45.1% | ILA19.34 Million | ILA42.88 Million | ILA23.54 Million | ▲ +16.8 pp |
| 2008 | 28.3% | ILA9.61 Million | ILA33.95 Million | ILA24.34 Million | ▼ -25.2 pp |
| 2007 | 53.5% | ILA5.71 Million | ILA10.67 Million | ILA4.96 Million | ▼ -30.3 pp |
| 2006 | 83.8% | ILA16.36 Million | ILA19.52 Million | ILA3.16 Million | — |